Malaria Drug Accelerator (MalDA)

The Malaria Drug Accelerator (MalDA) is a collaboration of 15 scientific laboratories funded by the Bill and Melinda Gates foundation to advance the development of new antimalarial drugs.

logo

Who are we?

The MALDA Consortium is an innovative target-guided discovery platform linking phenotypic hits to function for malaria. MALDA offers a new research paradigm that compliments the existing ways malaria drugs are discovered: A virtual pharmaceutical company.

How do we work together?

The MALDA Consortium is a collaboration between fifteen international groups, funded by BMGF.

MalDA Members

State-of-the-art
Plasmodium-adapted
technology platforms






In vitro selections
    State-of-Art Bioinformatics
    chemoinformatics / SAR / cryoEM
Conditional knockdown studies
     Essentiality assays
CRISPR-Cas9 reverse engineering
     Bar coded cell lines
     Overexpression lines
Metabolomics/Lipidomics/RNA-seq
     Macromolecule biosynthesis inhibitor assays
In vivo resistance evaluation

In vitro selections

  1. Clone by limiting dilution
  2. Select in triplicate
  3. Clone again
  4. Whole Genome Sequencing
  5. Compare genomes

External data
ChEMBL deposition data
Sequencing deposition data
Protocols

MalDA Publications

  1. Arendse, LB, Murithi, JM, Qahash, T, Pasaje, CFA, Godoy, LC, Dey, S et al.. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Sci Transl Med. 2022;14 (667):eabo7219. doi: 10.1126/scitranslmed.abo7219. PubMed PMID:36260689 .
  2. Laleu, B, Rubiano, K, Yeo, T, Hallyburton, I, Anderson, M, Crespo-Fernandez, B et al.. Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2. ChemMedChem. 2022;17 (22):e202200393. doi: 10.1002/cmdc.202200393. PubMed PMID:36129427 PubMed Central PMC9827907.
  3. Tye, MA, Payne, NC, Johansson, C, Singh, K, Santos, SA, Fagbami, L et al.. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance. Nat Commun. 2022;13 (1):4976. doi: 10.1038/s41467-022-32630-4. PubMed PMID:36008486 PubMed Central PMC9403976.
  4. Xie, SC, Metcalfe, RD, Dunn, E, Morton, CJ, Huang, SC, Puhalovich, T et al.. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy. Science. 2022;376 (6597):1074-1079. doi: 10.1126/science.abn0611. PubMed PMID:35653481 PubMed Central PMC7613620.
  5. Ottilie, S, Luth, MR, Hellemann, E, Goldgof, GM, Vigil, E, Kumar, P et al.. Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance. Commun Biol. 2022;5 (1):128. doi: 10.1038/s42003-022-03076-7. PubMed PMID:35149760 PubMed Central PMC8837787.
Search PubMed


Find us social!

MalDA selections

  • 200+ compounds under investigation
  • 400+ resistant clones generated for 58 compounds, and whole genome sequenced
  • 1300+ single nucleotide variants, 700+ indels, and 160+ copy number variants observed
  • At least 23 potential drug targets and 14 potential resistance genes identified or re-discovered using this method

Targets

  • PFK9
  • RFC4
  • ARK1
  • ATP4
  • KRS
  • cyto-IRS
  • FTB
  • PIP5K
  • ACS11
  • APP
  • DHFR-TS
  • PI4K
  • ATPase2
  • FP2A
  • NCR1
  • cPheRS
  • DHODH
  • RRB1
  • DPAP1
  • PRS

Resistance Genes

  • MFR3
  • ABCI3
  • CARL
  • MDR1
  • AAT1
  • CRT
  • PARE
  • YHM2
  • NEK1
  • MRP2
  • TKL3
  • CAF16
  • SulP
  • PF3D7_0909700

Compounds under consideration

  • 2,7-dibromo
    Cryptolepine hydrochloride (analog)
  • ACT-451840
  • Altiratinib
  • Anacetrapib
  • artemether
  • Atovaquone
  • AZ412
  • BI-1230
  • BI-1388
  • BI-2536
  • BRD1095
  • BRD3444
  • Brefeldin A
  • CEP-37440
  • cladosporin
  • Clofazimine
  • Cryptolepine hydrochloride
  • DDD01025389
  • DDD01057375
  • DDD01061024
  • DDD01250400
  • DDD01254473
  • DDD01298810
  • Decoquinate
  • Desoxyepothilone B
  • DSM265
  • ELQ300
  • GNF-Pf-1618
  • GNF-Pf-2740
  • GNF-Pf-2775
  • GNF-Pf-3582
  • GNF-Pf-3600
  • GNF-Pf-3703
  • GNF-Pf-4216
  • GNF-Pf-4283
  • GNF-Pf-445
  • GNF-Pf-4492
  • GNF-Pf-4577
  • GNF-Pf-5129
  • GNF-pf-5310
  • GNF-Pf-5349
  • GNF-Pf-5458
  • GNF-Pf-5611
  • GNF-Pf-5648
  • GNF-pf-5660
  • GNF-Pf-5666
  • GNF-pf-5668
  • GNF-Pf-5675
  • GNF179
  • GNF452
  • GNF707
  • indolmycin
  • Ivermectin
  • KAE609
  • KAF156
  • KAI407
  • KDU691
  • Lomitapide
  • lopinavir
  • Mefloquine
  • milciclib maleate
  • MMV000248
  • MMV000442
  • MMV000478
  • MMV000570
  • MMV000787
  • MMV006169
  • MMV006172
  • MMV006357
  • MMV006455
  • MMV006767
  • MMV006833
  • MMV006901
  • MMV006962
  • MMV007181
  • MMV007224
  • MMV007564
  • MMV008149
  • MMV009063
  • MMV009108
  • MMV010545
  • MMV011438
  • MMV011772
  • MMV011895
  • MMV011903
  • MMV019017
  • MMV019066
  • MMV019189
  • MMV019313
  • MMV019555
  • MMV019662
  • MMV019719
  • MMV019721
  • MMV019881
  • MMV019993
  • MMV020623
  • MMV020746
  • MMV020750
  • MMV021735
  • MMV022224
  • MMV022478
  • MMV023367
  • MMV023388
  • MMV023949
  • MMV023985
  • MMV024038
  • MMV024114
  • MMV024406
  • MMV026596
  • MMV027496
  • MMV027634
  • MMV028038
  • MMV028895
  • MMV029272
  • MMV030084
  • MMV030666
  • MMV032967
  • MMV064286
  • MMV084864
  • MMV084978
  • MMV085071
  • MMV085203
  • MMV1007245
  • MMV1010248
  • MMV1029508
  • MMV1030932
  • MMV1042937
  • MMV1044457
  • MMV1068987
  • MMV1079594
  • MMV1088520
  • MMV1091186
  • MMV1094822
  • MMV1147256
  • MMV1214532
  • MMV1223789
  • MMV1271410
  • MMV1291222
  • MMV1312865
  • MMV1317269
  • MMV1319550
  • MMV1371622
  • MMV1385304
  • MMV1394623
  • MMV1421890
  • MMV1425891
  • MMV1427995
  • MMV1430193
  • MMV1431916
  • MMV1432165
  • MMV1432711
  • MMV1449124
  • MMV1451822
  • MMV1454442
  • MMV1458543
  • MMV1468363
  • MMV1490397
  • MMV1490405
  • MMV1490583
  • MMV1501496
  • MMV1528403
  • MMV1531441
  • MMV396736
  • MMV396797
  • MMV407834
  • MMV665785
  • MMV665789
  • MMV665794
  • MMV665824
  • MMV665852
  • MMV665882
  • MMV665888
  • MMV665924
  • MMV665928
  • MMV665939
  • MMV665941
  • MMV665943
  • MMV665971
  • MMV666080
  • MMV666687
  • MMV667491
  • MMV668311
  • MMV668399
  • MMV673482
  • MMV673964
  • MMV675939
  • MMV676380
  • MMV676881
  • Naphthoquine
  • Neu-1029
  • NEU-1931
  • NEU-4995
  • NITD678
  • OSM-S-106
  • Pentamidine isothionate
  • pepstatin butyl ester
  • Piperaquine
  • primaquine
  • Puromycin
  • Sapanisertib
  • SQ109
  • Suloctidil
  • TCMDC-124553
  • TCMDC-135051
  • TCMDC-135395
  • Tryptanthrin
  • Velpatasvir
  • Verapamil
  • ZSTK-474
    • MalDA User Database (Password Required)
    Search PF identifier


    Search compound
    MalDA Public Database (No Password Required)

    Message us for inquiries regarding the MalDA project: ewinzeler@health.ucsd.edu

    Contact Us

    Google Scholar
    PubMed
    SRA (Sequence Read Archive)
    GEO (Gene Expression Omnibus)
    ChEMBL-NTD
    PlaTypUS Software

    Start typing and press Enter to search